FMC (FMC1) AI Stock Analysis
FMC
(BMV:FMC1)
No summary available
FMC (FMC1) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- MXN 776.41M
- Dividend Yield
- 3.59%
- Average Volume (3M)
- 2,200
- Price to Earnings (P/E)
- -0.2
- Beta (1Y)
- 0.03
- Revenue Growth
- -29.86%
- EPS Growth
- -639.94%
- Country
- Mexico
- Employees
- 5,500
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Agricultural Inputs
FMC Business Overview & Revenue Model
Company Description
FMC Corporation functions as an agricultural science enterprise, delivering products for crop safeguarding, plant wellness, and professional pest and turf management. The company is responsible for creating, commercializing, and selling various crop...
FMC Earnings Call Summary
The call had a negative near-term tone, driven by substantially below-expectation third-quarter results, large commercial action charges, lower fourth-quarter EBITDA guidance, negative 2026 free cash flow guidance, and ongoing pricing and demand pressures. Management presented a detailed recovery plan centered on channel inventory normalization, manufacturing cost reductions, new active ingredients, liquidity management, and expected EBITDA growth in 2027 and 2028, but execution of those actions remains the key focus.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Fourth quarter 2026 revenue is guided between $1.04 billion and $1.14 billion, about flat versus prior year at the midpoint, with volume growth offset by high single-digit price decline; adjusted EBITDA is expected to be between $210 million and $230 million, a decline of 22% versus the prior year, and adjusted earnings per share is expected to be between $0.56 and $0.70. Full year 2026 interest expense is expected to be in the range of $270 million to $280 million, depreciation and amortization between $160 million and $170 million, the effective tax rate on adjusted earnings 12% to 14%, and free cash flow in the range of negative $350 million to negative $150 million, including $180 million in restructuring spending, with free cash flow before restructuring expected to be negative $170 million to positive $30 million. FMC expects to end 2026 with net debt of approximately $3.1 billion with no outstanding revolver balance and to remain in compliance with all covenants through 2027. Preliminary 2027 adjusted EBITDA is expected to be at least $650 million and as much as $730 million, while 2028 adjusted EBITDA is expected to be approximately $760 million to $840 million; in 2027, the core business is expected to grow in the low single digit, the growth platform is expected to be up in the mid-teens, new active ingredients are expected to grow 50%, and the company has applied an EBITDA margin of 18% to 19% to its planning assumptions.
FMC Risk Analysis
FMC disclosed 48 risk factors in its most recent earnings report. FMC reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
2 New RisksFMC Peers Comparison
Overall Rating
CTVA74Outperform
ICL60Neutral
SMG48Neutral
AVD44Neutral
BIOX34Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| CTVA | 74Outperform | $7.77B | 51.28 | 4.08% | 0.93% | 3.70% | -26.39% |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| ICL | 60Neutral | $5.91B | 18.76 | 5.02% | 4.50% | 10.92% | -16.91% |
| SMG | 48Neutral | $3.62B | 49.79 | -21.87% | 4.24% | -1.95% | 44.91% |
| AVD | 44Neutral | $32.45M | -0.58 | -27.83% | ― | -3.54% | 56.67% |
| BIOX | 34Underperform | $13.15M | -0.06 | -216.09% | ― | -26.10% | 14.85% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MX:FMC1 | FMC Corp | 172.00 | -504.43 | -74.57% | |
| AVD | American Vanguard Corporation | 1.10 | -3.57 | -76.45% | |
| SMG | Scotts Miracle-Gro | 62.24 | 10.57 | 20.46% | |
| ICL | Icl Group Ltd. | 4.58 | -1.77 | -27.85% | |
| BIOX | Bioceres Crop Solutions | 0.21 | -1.65 | -88.82% | |
| CTVA | Corteva | 11.64 | 2.42 | 26.19% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.